Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder
A 12-week trial tests psilocybin’s potential to treat bipolar II depression, offering a glimpse into how psychedelics might reshape mental health care.
New and updated trials we’re tracking.
A 12-week trial tests psilocybin’s potential to treat bipolar II depression, offering a glimpse into how psychedelics might reshape mental health care.
A groundbreaking study explores if psilocybin combined with psychological support can safely treat PTSD and alcohol use disorder in veterans and first…
A Phase 4 trial exploring how anesthetics alter brain activity and consciousness across age groups.
A new trial is testing if inhaled DMT can fast-track relief for depression — and what it might reveal about the mind.
A study finds that two lion’s mane extracts may boost memory and mood—but the real surprise is how they change gut bacteria.